Walgreens Boots Alliance ( WBA) finalized a deal with Sycamore Partners worth up to $23.7 billion to take itself private ...

A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case against their PBMs.

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management business.

It has been 10 years since the first biosimilar was approved by the FDA. The grades on how the market for biosimilars has ...

Delving into the details, we found 62% of traders were bullish, while 12% showed bearish tendencies. Out of all the trades we ...

The “Big Three” PBMs are kicking their suit up to the 8th Circuit and, in the meantime, are once again asking a Missouri ...

CVS is a PBM through its CVS Caremark business. Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter @TomiKilgore.

CVS sees 23% revenue growth in healthcare benefits & projects 10% EPS in 2025, with Aetna recovery boosting performance.

FTC court order requires CVS Health to share more documents about Caremark Rx PBM practices as part of ongoing investigation ...

The state’s insurance regulator has demanded detailed information about patients and their medications, raising privacy ...